{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:42:45Z","timestamp":1789605765478,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation Thuthuka grant","award":["TTK2204214124"],"award-info":[{"award-number":["TTK2204214124"]}]},{"name":"South African Medical Research Council Self-Initiated Research (SIR) grant","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]},{"name":"L\u2019Or\u00e9al-UNESCO For Women in Science Programme","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37439-5","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:24:16Z","timestamp":1769322256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic implications of COVID-19 with a focus on lipid profiles and inflammatory markers"],"prefix":"10.1038","volume":"16","author":[{"given":"Farzahna","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sul\u00e9","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Currin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick J.","family":"Raal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail S.","family":"Kalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta M. E.","family":"Millen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"37439_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.clnesp.2021.07.023","volume":"45","author":"RK Mahat","year":"2021","unstructured":"Mahat, R. K. et al. Lipid profile as an indicator of COVID-19 severity: a systematic review and meta-analysis. Clin. Nutr. ESPEN. 45, 91\u2013101 (2021).","journal-title":"Clin. Nutr. ESPEN"},{"key":"37439_CR2","doi-asserted-by":"publisher","first-page":"12139","DOI":"10.1038\/s41598-024-62899-y","volume":"14","author":"LA Ochoa-Ram\u00edrez","year":"2024","unstructured":"Ochoa-Ram\u00edrez, L. A. et al. Association between lipid profile and clinical outcomes in COVID-19 patients. Sci. Rep. 14, 12139 (2024).","journal-title":"Sci. Rep."},{"key":"37439_CR3","doi-asserted-by":"crossref","unstructured":"Roccaforte, V., Daves, M., Lippi, G., Spreafico, M. & Bonato, C. Altered lipid profile in patients with COVID-19 infection. J. Lab. Precision Med. 6, 236 (2021).","DOI":"10.21037\/jlpm-20-98"},{"key":"37439_CR4","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.jlr.2021.100129","volume":"62","author":"KN Theken","year":"2021","unstructured":"Theken, K. N., Tang, S. Y., Sengupta, S. & FitzGerald, G. A. The roles of lipids in SARS-CoV-2 viral replication and the host immune response. J. Lipid Res. 62, 100129 (2021).","journal-title":"J. Lipid Res."},{"key":"37439_CR5","doi-asserted-by":"crossref","unstructured":"Cesar-Silva, D., Pereira-Dutra, F. S., Giannini, A. L. M., Maya-Monteiro, C. M. & de Almeida, C. J. G. Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. Front. Immunol. 14, 7456 (2023).","DOI":"10.3389\/fimmu.2023.1268854"},{"key":"37439_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5334\/gh.1128","volume":"17","author":"D Prabhakaran","year":"2022","unstructured":"Prabhakaran, D. et al. Cardiovascular risk factors and clinical outcomes among patients hospitalized with COVID-19: findings from the world heart federation COVID-19 study. Global Heart. 17, 40 (2022).","journal-title":"Global Heart"},{"key":"37439_CR7","doi-asserted-by":"publisher","unstructured":"Kronenberg, F. et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European atherosclerosis society consensus statement. Eur. Heart J. 2022, ehac361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac361 (2022).","DOI":"10.1093\/eurheartj\/ehac361"},{"key":"37439_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11883-022-01060-4","volume":"24","author":"NS Nurmohamed","year":"2022","unstructured":"Nurmohamed, N. S., Kraaijenhof, J. M. & Stroes, E. S. G. Lp(a): a new pathway to target? Curr. Atheroscler Rep. 24, 831\u2013838 (2022).","journal-title":"Curr. Atheroscler Rep."},{"key":"37439_CR9","doi-asserted-by":"crossref","unstructured":"Lee, M. P. et al. Ancestral diversity in lipoprotein(a) studies helps address evidence gaps. Open Heart 10, 4785 (2023).","DOI":"10.1136\/openhrt-2023-002382"},{"key":"37439_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11883-020-00867-3","volume":"22","author":"PM Moriarty","year":"2020","unstructured":"Moriarty, P. M. et al. Lipoprotein(a) and its potential association with thrombosis and inflammation in COVID-19: a testable hypothesis. Curr. Atheroscler Rep. 22, 48 (2020).","journal-title":"Curr. Atheroscler Rep."},{"key":"37439_CR11","unstructured":"Post COVID-19 condition (Long COVID). https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition (2025)."},{"key":"37439_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"37439_CR13","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care 47, S20\u2013S42 (2023).","DOI":"10.2337\/dc24-S002"},{"key":"37439_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.7196\/SAMJ.2018.v108i11.13383","volume":"108","author":"E Klug","year":"2018","unstructured":"Klug, E. et al. South African dyslipidaemia guideline consensus statement: 2018 update A joint statement from the South African heart association (SA heart) and the lipid and atherosclerosis society of Southern Africa (LASSA). S Afr. Med. J. 108, 973\u20131000 (2018).","journal-title":"S Afr. Med. J."},{"key":"37439_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2213-8587(22)00389-8","volume":"11","author":"P Durrington","year":"2023","unstructured":"Durrington, P. Blood lipids after COVID-19 infection. Lancet Diabetes Endocrinol. 11, 68\u201369 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"37439_CR16","doi-asserted-by":"crossref","unstructured":"Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583\u2013590 (2022).","DOI":"10.1038\/s41591-022-01689-3"},{"key":"37439_CR17","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1161\/HYPERTENSIONAHA.123.21174","volume":"80","author":"V Zhang","year":"2023","unstructured":"Zhang, V., Fisher, M., Hou, W., Zhang, L. & Duong, T. Q. Incidence of New-Onset hypertension Post\u2013COVID-19: comparison with influenza. Hypertension 80, 2135\u20132148 (2023).","journal-title":"Hypertension"},{"key":"37439_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejim.2023.10.016","volume":"119","author":"F Angeli","year":"2024","unstructured":"Angeli, F., Zappa, M. & Verdecchia, P. Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection. Eur. J. Intern. Med. 119, 31\u201333 (2024).","journal-title":"Eur. J. Intern. Med."},{"key":"37439_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12872-024-03916-w","volume":"24","author":"P Azami","year":"2024","unstructured":"Azami, P. et al. Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study. BMC Cardiovasc. Disord. 24, 240 (2024).","journal-title":"BMC Cardiovasc. Disord."},{"key":"37439_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12944-021-01563-0","volume":"20","author":"S Surma","year":"2021","unstructured":"Surma, S., Banach, M. & Lewek, J. COVID-19 and lipids. The role of lipid disorders and Statin use in the prognosis of patients with SARS-CoV-2 infection. Lipids Health Dis. 20, 141 (2021).","journal-title":"Lipids Health Dis."},{"key":"37439_CR21","doi-asserted-by":"crossref","unstructured":"Ozcan, M., Zhu, X., Zhang, H. & Javaheri, A. Editorial: lipids, lipoproteins and COVID-19. Front. Cardiovasc. Med. 10, 569 (2023).","DOI":"10.3389\/fcvm.2023.1293249"},{"key":"37439_CR22","unstructured":"Feingold, K. R. Lipid and lipoprotein levels in patients with COVID-19 infections. In Endotext (eds. Feingold, K. R. et al.) (MDText.com, Inc., 2000)."},{"key":"37439_CR23","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1038\/s41598-021-86747-5","volume":"11","author":"L Masana","year":"2021","unstructured":"Masana, L. et al. Low HDL and high triglycerides predict COVID-19 severity. Sci. Rep. 11, 7217 (2021).","journal-title":"Sci. Rep."},{"key":"37439_CR24","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.numecd.2021.06.016","volume":"31","author":"\u00c1 Aparisi","year":"2021","unstructured":"Aparisi, \u00c1. et al. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. Nutr. Metab. Cardiovasc. Dis. 31, 2619\u20132627 (2021).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"37439_CR25","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3390\/biomedicines10092320","volume":"10","author":"K Kowalska","year":"2022","unstructured":"Kowalska, K. et al. The influence of SARS-CoV-2 infection on lipid metabolism\u2014the potential use of lipid-Lowering agents in COVID-19 management. Biomedicines 10, 2320 (2022).","journal-title":"Biomedicines"},{"key":"37439_CR26","doi-asserted-by":"publisher","first-page":"585851","DOI":"10.3389\/fmed.2021.585851","volume":"8","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. Decreased low-density lipoprotein cholesterol level indicates poor prognosis of severe and critical COVID-19 patients: a retrospective, single-center study. Front. Med. 8, 585851 (2021).","journal-title":"Front. Med."},{"key":"37439_CR27","doi-asserted-by":"publisher","first-page":"604736","DOI":"10.3389\/fcvm.2021.604736","volume":"8","author":"J Gong","year":"2021","unstructured":"Gong, J. et al. U-Shaped relationship of Low-Density lipoprotein cholesterol with risk of severe COVID-19 from a multicenter pooled analysis. Front. Cardiovasc. Med. 8, 604736 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"37439_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12985-022-01865-4","volume":"19","author":"M Nain","year":"2022","unstructured":"Nain, M., Gupta, A., Malhotra, S. & Sharma, A. High-density lipoproteins May play a crucial role in COVID-19. Virol. J. 19, 135 (2022).","journal-title":"Virol. J."},{"key":"37439_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cvr\/cvu150","volume":"103","author":"AL Catapano","year":"2014","unstructured":"Catapano, A. L., Pirillo, A., Bonacina, F. & Norata, G. D. HDL in innate and adaptive immunity. Cardiovasc. Res. 103, 372\u2013383 (2014).","journal-title":"Cardiovasc. Res."},{"key":"37439_CR30","doi-asserted-by":"publisher","first-page":"166559","DOI":"10.1016\/j.bbadis.2022.166559","volume":"1868","author":"E Lo Presti","year":"2022","unstructured":"Lo Presti, E. et al. Molecular and pro-inflammatory aspects of COVID-19: the impact on cardiometabolic health. Biochim. Et Biophys. Acta (BBA) - Mol. Basis Disease. 1868, 166559 (2022).","journal-title":"Biochim. Et Biophys. Acta (BBA) - Mol. Basis Disease"},{"key":"37439_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.7150\/ijms.80498","volume":"20","author":"M Jovanovic","year":"2023","unstructured":"Jovanovic, M. et al. Increased pro Th1 and Th17 transcriptional activity in patients with severe COVID-19. Int. J. Med. Sci. 20, 530\u2013541 (2023).","journal-title":"Int. J. Med. Sci."},{"key":"37439_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/biomedicines10020296","volume":"10","author":"FJ Gil-Etayo","year":"2022","unstructured":"Gil-Etayo, F. J. et al. An early Th1 response is a key factor for a favorable COVID-19 evolution. Biomedicines 10, 296 (2022).","journal-title":"Biomedicines"},{"key":"37439_CR33","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/cells10061550","volume":"10","author":"D Martonik","year":"2021","unstructured":"Martonik, D., Parfieniuk-Kowerda, A., Rogalska, M. & Flisiak, R. The role of Th17 response in COVID-19. Cells 10, 1550 (2021).","journal-title":"Cells"},{"key":"37439_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S2213-8587(22)00355-2","volume":"11","author":"E Xu","year":"2023","unstructured":"Xu, E., Xie, Y. & Al-Aly, Z. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study. Lancet Diabets Endocrionol. 11, 120 (2023).","journal-title":"Lancet Diabets Endocrionol."},{"key":"37439_CR35","doi-asserted-by":"crossref","unstructured":"Condurache, D. G., Shanmuganathan, M., Raisi-Estabragh, Z. & Raman, B. Editorial: Post-COVID-19 cardiovascular sequelae. Front. Cardiovasc. Med. 10, 1191953 (2023).","DOI":"10.3389\/fcvm.2023.1191953"},{"key":"37439_CR36","doi-asserted-by":"crossref","unstructured":"Liang, Y., Liu, L. & Liang, B. COVID-19 susceptibility and severity for dyslipidemia: a Mendelian randomization investigation. Heliyon 9, 562 (2023).","DOI":"10.1016\/j.heliyon.2023.e20247"},{"key":"37439_CR37","doi-asserted-by":"publisher","first-page":"e0266814","DOI":"10.1371\/journal.pone.0266814","volume":"17","author":"A Pawlos","year":"2022","unstructured":"Pawlos, A., Gorzelak-Pabi\u015b, P., Staciwa, M. & Broncel, M. Elevated Lp(a) and course of COVID-19: is there a relationship? PLoS ONE. 17, e0266814 (2022).","journal-title":"PLoS ONE"},{"key":"37439_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2022.03.013","volume":"347","author":"M Montagnana","year":"2022","unstructured":"Montagnana, M. & Lippi, G. Lipoprotein(a) in COVID-19: genetics and inflammation collide. Atherosclerosis 347, 77\u201378 (2022).","journal-title":"Atherosclerosis"},{"key":"37439_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.13356","volume":"291","author":"B Enkhmaa","year":"2022","unstructured":"Enkhmaa, B. & Berglund, L. Lp(a) and SARS-CoV\u20102: a conspiracy of two mysteries. J. Intern. Med. 291, 8\u201310 (2022).","journal-title":"J. Intern. Med."},{"key":"37439_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2022.07.015","volume":"357","author":"M Kaltoft","year":"2022","unstructured":"Kaltoft, M. et al. Lipoprotein(a) during COVID-19 hospitalization: thrombosis, inflammation, and mortality. Atherosclerosis 357, 33\u201340 (2022).","journal-title":"Atherosclerosis"},{"key":"37439_CR41","doi-asserted-by":"crossref","unstructured":"Bianconi, V. et al. Lipoprotein(a) does not predict thrombotic events and in-hospital outcomes in patients with COVID-19. JCM 12, 3543 (2023).","DOI":"10.3390\/jcm12103543"},{"key":"37439_CR42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11239-021-02597-y","volume":"53","author":"G Lippi","year":"2022","unstructured":"Lippi, G. et al. The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. J. Thromb. Thrombolysis. 53, 581\u2013585 (2022).","journal-title":"J. Thromb. Thrombolysis"},{"key":"37439_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003354","author":"BA Satterfield","year":"2021","unstructured":"Satterfield, B. A. et al. Associations of genetically predicted Lp(a) (Lipoprotein [a]) levels with cardiovascular traits in individuals of European and African ancestry. Circ. Genomic Precis. Med. https:\/\/doi.org\/10.1161\/CIRCGEN.120.003354 (2021).","journal-title":"Circ. Genomic Precis. Med."},{"key":"37439_CR44","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/cvr\/cvab100","volume":"118","author":"DI Swerdlow","year":"2022","unstructured":"Swerdlow, D. I. et al. Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics. Cardiovascular. Res. 118, 1218\u20131231 (2022).","journal-title":"Cardiovascular. Res."},{"key":"37439_CR45","doi-asserted-by":"publisher","first-page":"107948","DOI":"10.1016\/j.isci.2023.107948","volume":"26","author":"A S\u00e1nchez","year":"2023","unstructured":"S\u00e1nchez, A. et al. Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery. iScience 26, 107948 (2023).","journal-title":"iScience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37439-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:41:22Z","timestamp":1770975682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37439-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37439"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37439-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6613080\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6217"}}